Exogenous activation of delta- and kappa-opioid receptors affords cardioprotection in isolated murine heart.
Controversy exists regarding the relative roles of delta- and kappa-opioid receptor activation as a potential cardioprotective mechanism. Furthermore, the function of opioid receptor activation in cardioprotection has not been examined in the murine heart. To this end, we employed various concentrations of selective delta - and kappa-opioid receptor agonists in an isolated murine heart model undergoing 20 min global ischemia followed by 45 min reperfusion. Left-ventricular developed pressure (LVDP) returned to 50.7 +/- 2.1% of baseline values in untreated hearts. Infusion of the non-selective opioid agonist, morphine (10 micro M), lead to a marked improvement in post-ischemic contractile recovery where LVDP returned to 65.5 +/- 2.4% of baseline function. The delta-opioid selective agonist BW373U86 hydrochloride elicited maximal protection at a concentration of 1 micro M which afforded 63.9 +/- 3.4% recovery of LVDP. This effect was blocked by the delta-opioid selective antagonist, BNTX. Furthermore, administration of the kappa-opioid selective agonist U50,488 (1 micro M) produced a marked improvement in contractile recovery leading to a 72.5 +/- 5.3% recovery of LVDP. This degree of protection was also abolished by the kappa-opioid receptor antagonist, nor-BNI. No differences were noted in LDH efflux from post-ischemic hearts. These data suggest that exogenous activation of delta- and kappa-opioid receptors afford protection against myocardial stunning in the isolated murine heart, an effect attenuated by selective receptor antagonists.